Navigation Links
A new genre of 'intelligent' micro- and nanomotors
Date:1/30/2013

Enzymes, workhorse molecules of life that underpin almost every biological process, may have a new role as "intelligent" micro- and nanomotors with applications in medicine, engineering and other fields. That's the topic of a report in the Journal of the American Chemical Society, showing that single molecules of common enzymes can generate enough force to cause movement in specific directions.

Peter J. Butler, Ayusman Sen and colleagues point out that enzymes proteins that jump-start chemical reactions are the basis of natural biological motors essential to life. Scientists long have wondered whether a single enzyme molecule, the smallest machine that could possibly exist, might be able to generate enough force to cause its own movement in a specific direction. "Positive answers to these questions," they explain, "have important implications in areas ranging from biological transport to the design of 'intelligent,' enzyme-powered, autonomous nano- and micromotors, which are expected to find applications in bottom-up assembly of structures, pattern formation, cargo (drug) delivery at specific locations, roving sensors and related functions."

They provide the positive answers in experiments with two common enzymes called catalase and urease. Catalase protects the body from harmful effects of hydrogen peroxide formed naturally in the course of life. Urease, found in many plants, converts urea to ammonia and carbon dioxide. The researchers show that these two enzymes, in the presence of their respective substrate (hydrogen peroxide or urea, which acts as fuel), show movement. More significantly, the movement becomes directional through the imposition of a substrate gradient, a form of chemotaxis. Chemotaxis is what attracts living things toward sources of food. The researchers also show that movement causes chemically interconnected enzymes to be drawn together; a form of predator-prey behavior at the nanoscale.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. A new genre of diagnostic tests for the era of personalized medicine
2. Canada and Europe fund intelligent senior homes
3. Targeted micro-bubbles detect artery inflammation, MU study finds
4. Katon Direct, a Healthcare Micro-Marketing Solutions Company, Launches Their New Website, Innovating the way Healthcare Companies Find the Most Qualified Candidates
5. Micro-Stents May Hold Potential to Treat Glaucoma
6. In obesity, a micro-RNA causes metabolic problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... How to Write Error Free Procedures, **Presented by Ginette M. Collazo and ... known to be the major cause of quality and production losses in many industries. ... performance problems can be prevented. , How to Write Error Free Procedures, part two ...
(Date:5/24/2016)... CA (PRWEB) , ... May 24, 2016 , ... Loma ... house the new adult hospital and expanded Children’s Hospital. Over 3,000 people looked on ... , Check out the event photo slidehsow. , During the program, Richard ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... freezing, today announced the official relaunch of its community and education hub for ... eggs. Eggsurance's mission is to create a safe and welcoming place for women ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Tuesday, May 24, ... The Yoga practice enhanced with Young Living Essential Oils, taught by Patti Dolan, RYT, ... the Lake Orion location. Yoga Flow is 6:30pm - 7:15pm followed by a small ...
(Date:5/24/2016)... DeLand, Florida (PRWEB) , ... May 24, 2016 , ... ... to make residents aware of the potential of contaminated well water throughout the Houston ... is homes supplied with well water that’s exposed to contaminants. Residents may not even ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology: